Activation of the Lymphotoxin β Receptor by Cross-Linking Induces Chemokine Production and Growth Arrest in A375 Melanoma Cells

Journal of Immunology

Volumn 158, Issue 4, 1997, Pages 1756-1762

  Degli Esposti, Mariapia A ^a   Davis Smith, Terri ^a   Din, Wenie S ^a   Smolak, Pamela J ^a   Goodwin, Raymond G ^a   Smith, Craig A ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; CHEMOKINE; CROSS LINKING REAGENT; GROWTH INHIBITOR; IMMUNOGLOBULIN FC FRAGMENT; LTB PROTEIN, HUMAN; LTBR PROTEIN, HUMAN; LYMPHOTOXIN; LYMPHOTOXIN BETA; LYMPHOTOXIN BETA RECEPTOR; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; FETUS; HUMAN; IMMUNOLOGY; MELANOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; SOLUBILITY; TISSUE DISTRIBUTION;

ADULT; ANTIBODIES, MONOCLONAL; BIOPOLYMERS; CHEMOKINES; CROSS-LINKING REAGENTS; FETUS; GROWTH INHIBITORS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MELANOMA; MEMBRANE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SOLUBILITY; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0031568649     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Baens, M., M. Chaffanet, J.-J. Cassiman, H. van den Berghe, and P. Marynen. 1993. Construction and evaluation of a hncDN A library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16:214.
2. Smith, C. A., T. Davis, D. Anderson, L. Solam, M. P. Beckmann, R. Jerzy, S. K. Dower, D. Cosman, and R. G. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019.
3. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959.
4. Smith, C. A., and R. G. Goodwin. 1994. Tumor necrosis factor receptors in the poxvirus family: biological and genetic implications. In Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses. G. McFadden, ed. R. G. Landes Company, Austin, TX, p. 29.
5. Loetscher, H., R. Gentz, M. Zulauf, A. Lustig, H. Tabuchi, E.-J. Schlaeger, M. Brockhaus, H. Gallati, M. Manneberg, and W. Lesslauer. 1991. Recombinant 55-kDa tumor necrosis factor (TNF) receptor: stoichiometry of binding to TNFα and TNFβ and inhibition of TNF activity. J. Biol. Chem. 266:18324.
6. Browning, J. L., I. Dougas, A. Ngam-ek, P. R. Bourdon, B. N. Ehrenfels, K. Miatkowski, M. Zafari, A. M. Yampaglia, P. Lawton, W. Meier, C. P. Benjamin, and C. Hession. 1995. Characterization of surface lymphotoxin forms: use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154:33.
7. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. G. Goodwin, and C. A. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707.
8. Force, W. R., B. N. Walter, C. Hession, R. Tizard, C. A. Kozak, J. L. Browning, and C. F. Ware. 1995. Mouse lymphotoxin-β receptor. Molecular genetics, ligand binding, and expression. J. Immunol. 155:5280.
9. Browning, J. L., K. Miatkowski, D. A. Griffiths, P. R. Bourdon, C. Hession, C. M. Ambrose, and W. Meier. 1996. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins α and β. J. Biol. Chem. 271:8618.
10. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703.
11. Pfeffer K., T. Matsuyama, T. M. Kündig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Krönke, and T. W. Mak. 1993. Mice deficient for the 55-kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457.
12. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798.
13. Erickson, S. L., F. J. de Sauvage, K. Kikly, K. Carver-Moore, S. Pitts-Meek, N. Gillett, K. C. Sheehan, R. D. Schreiber, D. V. Goeddel, and M. W. Moore. 1994. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560.
14. Eck, M. J., and S. R. Sprang. 1989. The structure of tumor necrosis factor-α at 2.6 Å resolution: implications for receptor binding. J. Biol. Chem. 264:17595.
15. Eck, M. J., M. Ultsch, E. Rinderknecht, A. M. de Vos, and S. R. Sprang. 1992. The structure of human lymphotoxin (tumor necrosis factor-β) at 1.9-Å resolution. J. Biol. Chem. 267:2119.
16. Jones, E. Y., D. I. Stuart, and N. P. C. Walker. 1989. Structure of tumour necrosis factor. Nature 338:225.
17. Banner, D. W., A. D'Arcy, W. Janes, R. Gentz, H.-J. Schoenfeld, C. Broger, H. Loetscher, and W. Lesslauer. 1993. Crystal structure of the soluble human 55-kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell 73:431.
18. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
19. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the 1L-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
20. Fanslow, W. C., D. Anderson, K. H. Grabstein, E. A. Clark, D. Cosman, and R. J. Armitage. 1992. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149:655.
21. Hopp, T. P., K. S. Prickett, V. L. Price, R. T. Liggy, C. J. March, D. P. Cerretti, D. L. Urdal, and P. J. Conlon. 1988. A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology 6:1204.
22. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
23. Flick, D. A., and G. E. Gifford. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68:167.
24. Alderson, M. R., C. A. Smith, T. W. Tough, T. Davis-Smith, R. J. Armitage, B. Falk, E. Roux, E. Baker, G. R. Sutherland, W. S. Din, and R. G. Goodwin. 1994. Molecular and biological characterization of human 4-1BB and its ligand. Eur. J. Immunol. 24:2219.
25. Cosman, D. 1994. A family of ligands for the TNF receptor superfamily. Stem Cells 12:440.
26. Browning, J. L., K. Miatkowski, I. Sizing, D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867.
27. Engelmann, H., H. Holtmann, C. Brakebusch, Y. S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265-14497.
28. Pennica, D., V. T. Lam, N. K. Mize, R. F. Weber, M. Lewis, B. M. Fendly, M. T. Lipari, and D. V. Goeddel. 1992. Biochemical properties of the 75-kDa tumor necrosis factor receptor. J. Biol. Chem. 267:21172.
29. Pennica, D., V. T. Lam, R. F. Weber, W. J. Kohr, L. J. Basa, M. W. Spellman, A. Ashkenazi, S. J. Shire, and D. V. Goeddel. 1993. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Biochemistry 32:3131.
30. van Lier, R. A. W., J. Borst, T. M. Vroom, H. Klein, P. Van Mourik, W. P. Zeijlemaker, and C. J. M. Melief. 1987. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.. J. Immunol. 139:1589.
31. Espevik, T., M. Brockhaus, H. Loetscher, U. Nonstad, and R. Shalaby. 1990. Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J. Exp. Med. 171:415.
32. Banchereau, J., and F. Rousset. 1991. Growing human B lymphocytes in the CD40 system. Nature 353:678.
33. Sugita, K., Y. Torimoto, Y. Nojima, J. F. Daley, S. F. Schlossman, and C. Morimoto. 1991. The 1A4 molecule (CD27) is involved in T cell activation. J. Immunol. 147:1477.
34. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, Jr., and D. V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292.
35. Calderhead, D. M., J. E. Buhlmann, A. J. M. van den Eertwegh, E. Claassen, R. J. Noelle, and H. P. Fell. 1993. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151:5261.
36. Smith, C. A., H.-J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G. R. Sutherland, C. I. Brannan, N. G. Copeland, N. A. Jenkins, K. H. Grabstein, B. Gliniak, I. B. McAlister, W. Fanslow, M. Alderson, B. Falk, S. Gimpel, S. Gillis, W. S. Din, R. G. Goodwin, and R. J. Armitage. 1993. CD30 antigen" a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349.
37. de Vos, A. M., M. Ultsch, and A. A. Kossiakoff. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306.
38. Bazzoni, F., E. Alejos, and B. Beutler. 1995. Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc. Natl. Acad. Sci. USA 92: 5376.